Prostate Cancer Screening: A Primary Care Survey (Report‪)‬

1. INTRODUCTION Prostate cancer is the most common form of non-skin cancer among men in the United States. It is the second leading cause of cancer deaths in American men, after lung cancer, and the sixth leading cause of death overall for men in this country [1]. American men have a 1 in 6 chance of developing prostate cancer in their lifetime and a 1 in 30 chance of dying from prostate cancer. Most of the deaths from prostate cancer are related to advanced disease that could have potentially been prevented with better screening practices. However, multiple non-urology driven groups propose less or no screening for prostate cancer. Continuous advances have provided a new understanding of the diagnosis, staging, and treatment of metastatic and advanced prostate cancer and the potential benefits of early screening programs. Despite these ongoing improvements, prostate cancer is unlike any other tumor, the natural history is that it will progress over time but the unanswered question is over what period of time.